heart problems: LENVIMA can cause serious heart problems that may lead to death.If you develop blood pressure problems, your healthcare provider may prescribe medicine to treat your high blood pressure. Provider should check your blood pressure regularly during treatment with LENVIMA. Your blood pressure should be well controlled before you start taking LENVIMA. high blood pressure (hypertension): High blood pressure is a common side effect of LENVIMA and can be serious.LENVIMA may cause serious side effects, including: Important Safety Information and Indications This card may not be accepted at all pharmacies. The value of this program is not contingent on any prior or future purchases. Patients and pharmacies are responsible for disclosing to insurance carriers the redemption and value of the program and complying with any other conditions imposed by insurance carriers, third-party payers, and applicable law on the redemption. You must be 18 years or older to use this card for yourself or a minor. reserves the right to rescind, revoke, or amend this offer at any time without notice. Void outside the USA and where prohibited by law. Federal law prohibits the selling, purchasing, trading, or counterfeiting of this card. Program is not valid for cash paying customers. May not be combined with any other discount or offer. Save this information for reuse with each prescription. Not valid for LENVIMA prescriptions reimbursed in full by any third-party payer. Offer only available to patients with private, commercial insurance. Not available to patients enrolled in state or federal health care programs, including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai’s maximum liability. The LENVIMA $0 Co-pay Program provides up to a maximum of $40,000 per year to assist with the out-of-pocket costs for LENVIMA. Terms and Conditions: Good toward the purchase of LENVIMA prescriptions. All services must be medically appropriate and properly supported in the patient medical record. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. For additional information, customers should consult with their payers for all relevant coding, reimbursement, and coverage requirements. Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims. Coding, coverage, and reimbursement may vary significantly by payer, plan, patient, and setting of care. *Eisai cannot guarantee payment of any claim. It is not known if LENVIMA is safe and effective in children. Studies are ongoing to provide additional information about clinical benefit. This use is approved based on how many patients responded to treatment and how long they responded. that cannot be treated with surgery or radiation. that has progressed after treatment with anti-cancer medicine, and.that is not microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR), and.LENVIMA is used along with another medicine called pembrolizumab to treat advanced endometrial carcinoma, a type of uterine cancer:.LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.LENVIMA is used along with another medicine called everolimus to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC) after one course of treatment with another anti-cancer medicine.LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.LENVIMA® (lenvatinib) is a prescription medicine that is used to treat people with certain kinds of cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |